Results 1 to 10 of about 2,797 (225)

Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity [PDF]

open access: goldOrphanet Journal of Rare Diseases, 2017
Background Without neonatal initiation of treatment, 80–90% of patients with glutaric aciduria type 1 (GA1) develop striatal injury during the first six years of life resulting in a complex, predominantly dystonic movement disorder.
Nikolas Boy   +6 more
doaj   +7 more sources

Glutaric Aciduria Type I Missed by Newborn Screening: Report of Four Cases from Three Families [PDF]

open access: goldInternational Journal of Neonatal Screening, 2021
Glutaric aciduria type I (GA-1) is a rare autosomal-recessive disorder of the degradation of the amino acids lysine and tryptophan caused by mutations of the GCDH gene encoding glutaryl-CoA-dehydrogenase.
Johannes Spenger   +13 more
doaj   +4 more sources

Rescue of glutaric aciduria type I in mice by liver-directed therapies. [PDF]

open access: greenSci Transl Med, 2023
Glutaric aciduria type I (GA-1) is an inborn error of metabolism with a severe neurological phenotype caused by the deficiency of glutaryl-coenzyme A dehydrogenase (GCDH), the last enzyme of lysine catabolism.
Barzi M   +21 more
europepmc   +5 more sources

Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I. [PDF]

open access: goldPLoS ONE, 2013
Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) is an inborn error of metabolism that usually manifests in infancy by an acute encephalopathic crisis and often results in permanent motor handicap.
Paris Jafari   +5 more
doaj   +4 more sources

Audiological and otologic manifestations of glutaric aciduria type I [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2020
Background Glutaric aciduria type 1 (GA-1) is a rare disease connected with speech delay and neurological deficits. However, the audiological and otologic profiles of GA-1 have not yet been fully characterized. To our knowledge, this is the largest study
Yen-Chi Chen   +8 more
doaj   +5 more sources

Formation of 3‐hydroxyglutaric acid in glutaric aciduria type I: in vitro participation of medium chain acyl‐CoA dehydrogenase [PDF]

open access: goldJIMD Reports, 2019
3‐Hydroxyglutaric acid (3‐OH‐GA) in urine has been identified as the most reliable diagnostic marker for glutaric aciduria type I (GA I). We showed that hydratation of glutaconyl‐CoA to 3‐hydroxyglutaryl‐CoA, which is subsequently hydrolyzed to 3‐OH‐GA ...
Verena Peters   +8 more
doaj   +4 more sources

Diagnosis of glutaric aciduria type I based on neuroradiological findings: when neonatal screening fails [PDF]

open access: yesItalian Journal of Pediatrics
Background Glutaric aciduria type I (GA-I) is an autosomal recessive disorder affecting the metabolism of lysine, hydroxylysine, and tryptophan. Patients present in the first age of life with an irreversible motor disorder, and neuroradiological imaging ...
Vincenza Gragnaniello   +8 more
doaj   +4 more sources

Glutaric aciduria type I: A treatable neurometabolic disorder

open access: yesAnnals of Indian Academy of Neurology, 2012
Background and Objectives: Glutaric aciduria Type-I (GA-I) has characteristic clinical and neuroimaging features, which clinches the diagnosis in a majority of patients. However, there have been few case reports on GA-I from India.
Mahesh Kamate   +4 more
doaj   +4 more sources

Diagnosis and management of glutaric aciduria type I--revised recommendations. [PDF]

open access: yesJ Inherit Metab Dis, 2011
Glutaric aciduria type I (synonym, glutaric acidemia type I) is a rare organic aciduria. Untreated patients characteristically develop dystonia during infancy resulting in a high morbidity and mortality. The neuropathological correlate is striatal injury
Kölker S   +18 more
europepmc   +9 more sources

Treatment of glutaric aciduria type I (GA-I) via intracerebroventricular delivery of GCDH [PDF]

open access: yesFundamental Research, 2022
Glutaric aciduria type I (GA-I) is an autosomal recessive genetic disorder caused by a deficiency in glutaryl-CoA dehydrogenase (GCDH). Patients who do not receive proper treatment may die from acute encephalopathic crisis.
Lu Guo   +12 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy